Compliance Corner: US FDA Wants Device Firms To Fully Consider Risks To Consumers, Agency Expert Says
Executive Summary
Manufacturers that don't consider all possible dangers their products can pose to consumers is a growing problem, FDA's national expert on devices says. Phil Pontikos also is worried that firms aren't putting their best foot forward when using risk assessment tools.
You may also be interested in...
It's A Green Light For ISO 13485: Revised Global Quality Systems Standard Finally Published
After five years of high-stakes development, ISO 13485:2016 was published on Feb. 24. The 36-page worldwide quality systems standard carries an official publishing date of March 1, which means firms have until March 1, 2019, to comply.
Speaking Of Medtech, Ep. 10: FDA’s TAP Pilot
In this FINAL EPISODE of Speaking Of Medtech: The US FDA got something it desperately wanted in its latest user-fee package with industry: a Total Product Lifecycle Advisory Program pilot, or TAP. The agency says TAP will allow for earlier and more frequent engagement with developers – but is it needed?
Thumbs Up: FDA Authorizes Weight Loss Suturing Systems From Apollo Endosurgery
People with obesity now have new tools to help them lose weight, thanks to the US agency’s de novo authorization.